Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial

Journals

1. Lim S, Ong K, Johal J, Han C, Yap Q, Chan Y, Chooi Y, Zhang Z, Chandra C, Thiagarajah A, Khoo C. Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes. JAMA Network Open 2021;4(6):e2112417 View
2. Buzzetti E, Linden A, Best L, Madden A, Roberts D, Chase T, Freeman S, Cooper N, Sutton A, Fritche D, Milne E, Wright K, Pavlov C, Davidson B, Tsochatzis E, Gurusamy K. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021;2021(6) View
3. O'Gorman P, Norris S. Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD). BMJ Open Gastroenterology 2021;8(1):e000568 View
4. Motz V, Faust A, Dahmus J, Stern B, Soriano C, Stine J. Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study. JMIR Formative Research 2021;5(8):e30239 View
5. Chew H, Lim S, Kim G, Kayambu G, So B, Shabbir A, Gao Y. Essential elements of weight loss apps for a multi-ethnic population with high BMI: a qualitative study with practical recommendations. Translational Behavioral Medicine 2023 View
6. Kwon O, Choi J, Jang Y. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis. Journal of Medical Internet Research 2023;25:e37487 View
7. Lim S, Ong K, Johal J, Han C, Yap Q, Chan Y, Zhang Z, Chandra C, Thiagarajah A, Khoo C. A Smartphone App-Based Lifestyle Change Program for Prediabetes (D'LITE Study) in a Multiethnic Asian Population: A Randomized Controlled Trial. Frontiers in Nutrition 2022;8 View
8. Iruzubieta P, Bataller R, Arias-Loste M, Arrese M, Calleja J, Castro-Narro G, Cusi K, Dillon J, Martínez-Chantar M, Mateo M, Pérez A, Rinella M, Romero-Gómez M, Schattenberg J, Zelber-Sagi S, Crespo J, Lazarus J. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease 2023;27(2):535 View
9. Ang S, Chen J, Liew J, Johal J, Dan Y, Allman-Farinelli M, Lim S. Efficacy of Interventions That Incorporate Mobile Apps in Facilitating Weight Loss and Health Behavior Change in the Asian Population: Systematic Review and Meta-analysis. Journal of Medical Internet Research 2021;23(11):e28185 View
10. Lim S, Tay M, Ong K, Johal J, Yap Q, Chan Y, Yeo G, Khoo C, Yaxley A. Association Between Mobile Health App Engagement and Weight Loss and Glycemic Control in Adults With Type 2 Diabetes and Prediabetes (D’LITE Study): Prospective Cohort Study. JMIR Diabetes 2022;7(3):e35039 View
11. Chai X, Zhou B, Ning N, Pan T, Xu F, He S, Chen N, Sun M. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis. Frontiers in Endocrinology 2023;14 View
12. Arora C, Malhotra A, Ranjan P, Singh V, Singh N, Shalimar , Dwivedi S, Vikram N. Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT. European Journal of Clinical Nutrition 2022;76(9):1332 View
13. Kosmalski M, Frankowski R, Ziółkowska S, Różycka-Kosmalska M, Pietras T. What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). Journal of Clinical Medicine 2023;12(5):1852 View
14. Stine J, Rivas G, Hummer B, Duarte-Rojo A, May C, Geyer N, Chinchilli V, Conroy D, Mitchell E, McCallum M, Michealides A, Schmitz K. Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH. Hepatology Communications 2023;7(4) View
15. Lazarus J, Villota-Rivas M, Jiménez-González C, Santos-Laso A, Iruzubieta P, Arias-Loste M, Rice-Duek L, Leigh S, Kopka C, Turnes J, Calleja J, Crespo J. Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2023;27(2):515 View
16. Zhou R, Gu Y, Zhang B, Kong T, Zhang W, Li J, Shi J. Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology 2023;14(4):e00575 View
17. Baechle C, Lang A, Strassburger K, Kuss O, Burkart V, Szendroedi J, Müssig K, Weber K, Schrauwen-Hinderling V, Herder C, Roden M, Schlesinger S. Association of a lifestyle score with cardiometabolic markers among individuals with diabetes: a cross-sectional study. BMJ Open Diabetes Research & Care 2023;11(4):e003469 View
18. Seifi N, Bahari H, Soltani S, Nikoumanesh M, Hajipoor M, Ferns G, Ghayour-Mobarhan M. The effects of electronic-based lifestyle interventions on nonalcoholic fatty liver disease: A systematic review. DIGITAL HEALTH 2023;9 View
19. Muftah A, Banala C, Raasikh T, Jamali T, Bustamante G, Cholankeril G, Kanwal F, Flores A, Hernaez R. Telehealth interventions in patients with chronic liver diseases: A systematic review. Hepatology 2023;78(1):179 View
20. Lazarus J, Mark H, Allen A, Arab J, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani S, Arrese M, Bataller R, Berg T, Brennan P, Burra P, Castro-Narro G, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque S, Hagström H, Huang T, Wajcman D, Kautz A, Kopka C, Krag A, Miller V, Newsome P, Rinella M, Romero D, Sarin S, Silva M, Spearman C, Tsochatzis E, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg J, Wong V, Younossi Z, Lazarus J, Huang T, Aberg F, Adams L, Al-Naamani K, Albadawy R, Alexa Z, Allison M, Alnaser F, Alswat K, Alvares-da-Silva M, Alvaro D, Alves-Bezerra M, Andrade R, Anstee Q, Awuku Y, Baatarkhuu O, Baffy G, Bakieva S, Bansal M, Barouki R, Batterham R, Behling C, Belfort-DeAguiar R, Berzigotti A, Betel M, Bianco C, Bosi E, Boursier J, Brunt E, Bugianesi E, Byrne C, Cabrera Cabrejos M, Caldwell S, Carr R, Castellanos Fernández M, Castera L, Castillo-López M, Caussy C, Cerda-Reyes E, Ceriello A, Chan W, Chang Y, Charatcharoenwitthaya P, Chavez-Tapia N, Chung R, Colombo M, Coppell K, Cotrim H, Craxi A, Crespo J, Dassanayake A, Davidson N, De Knegt R, de Ledinghen V, Demir M, Desalegn H, Diago M, Dillon J, Dimmig B, Dirac M, Dirchwolf M, Dufour J, Dvorak K, Ekstedt M, El-Kassas M, Elsanousi O, Elsharkawy A, Elwakil R, Eskridge W, Eslam M, Esmat G, Fan J, Ferraz M, Flisiak R, Fortin D, Fouad Y, Freidman S, Fuchs M, Gadano A, Gastaldelli A, Geerts A, Geier A, George J, Gerber L, Ghazinyan H, Gheorghe L, Kile D, Girala M, Boon Bee G, Goossens N, Graupera I, Grønbæk H, Hamid S, Hebditch V, Henry Z, Hickman I, Hobbs L, Hocking S, Hofmann W, Idilman R, Iruzubieta P, Isaacs S, Isakov V, Ismail M, Jamal M, Jarvis H, Jepsen P, Jornayvaz F, Sudhamshu K, Kakizaki S, Karpen S, Kawaguchi T, Keating S, Khader Y, Kim S, Kim W, Kleiner D, Koek G, Joseph Komas N, Kondili L, Koot B, Korenjak M, Kotsiliti E, Koulla Y, Kugelmas C, Kugelmas M, Labidi A, Lange N, Lavine J, Lazo M, Leite N, Lin H, Lkhagvaa U, Long M, Lopez-Jaramillo P, Lozano A, Macedo M, Malekzadeh R, Marchesini G, Marciano S, Martinez K, Martínez Vázquez S, Mateva L, Mato J, Nlombi C, McCary A, McIntyre J, McKee M, Mendive J, Mikolasevic I, Miller P, Milovanovic T, Milton T, Moreno-Alcantar R, Morgan T, Motala A, Muris J, Musso C, Nava-González E, Negro F, Nersesov A, Neuschwander-Tetri B, Nikolova D, Norris S, Novak K, Ocama P, Ong J, Ong-Go A, Onyekwere C, Padilla M, Pais R, Pan C, Panduro A, Panigrahi M, Papatheodoridis G, Paruk I, Patel K, Gonçalves C, Figueroa M, Pérez-Escobar J, Pericàs J, Perseghin G, Pessoa M, Petta S, Marques Souza de Oliveira C, Prabhakaran D, Pyrsopoulous N, Rabiee A, Ramji A, Ratziu V, Ravendhran N, Ray K, Roden M, Romeo S, Romero-Gómez M, Rotman Y, Rouabhia S, Rowe I, Sadirova S, Alkhatry M, Salupere R, Satapathy S, Schwimmer J, Sebastiani G, Seim L, Seki Y, Serme A, Shapiro D, Sharvadze L, Shaw J, Shawa I, Shenoy T, Shibolet O, Shimakawa Y, Shubrook J, Singh S, Sinkala E, Skladany L, Skrypnyk I, Song M, Sookoian S, Sridharan K, Stefan N, Stine J, Stratakis N, Sheriff D, Sundaram S, Svegliati-Baroni G, Swain M, Tacke F, Taheri S, Tan S, Tapper E, Targher G, Tcaciuc E, Thiele M, Tiniakos D, Tolmane I, Torre A, Torres E, Treeprasertsuk S, Trenell M, Turcan S, Turcanu A, Valantinas J, van Kleef L, Velarde Ruiz Velasco J, Vesterhus M, Vilar-Gomez E, Waked I, Wattacheril J, Wedemeyer H, Wilkins F, Willemse J, Wong R, Yilmaz Y, Yki-Järvinen H, Yu M, Yumuk V, Zeybel M, Zheng K, Zheng M. A global research priority agenda to advance public health responses to fatty liver disease. Journal of Hepatology 2023;79(3):618 View
21. Balakrishnan M, Liu K, Schmitt S, Heredia N, Sisson A, Montealegre J, Hernaez R, Kanwal F, Foreyt J. Behavioral weight-loss interventions for patients with NAFLD: A systematic scoping review. Hepatology Communications 2023;7(8) View
22. Joshi S, Shamanna P, Dharmalingam M, Vadavi A, Keshavamurthy A, Shah L, Mechanick J. Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study. Endocrine Practice 2023;29(12):960 View
23. Han C, Lim S, Ong K, Johal J, Gulyani A. Behavioral Lifestyle Intervention Program Using Mobile Application Improves Diet Quality in Adults With Prediabetes (D’LITE Study): A Randomized Controlled Trial. Journal of the Academy of Nutrition and Dietetics 2023 View
24. Björnsdottir S, Ulfsdottir H, Gudmundsson E, Sveinsdottir K, Isberg A, Dobies B, Akerlie Magnusdottir G, Gunnarsdottir T, Karlsdottir T, Bjornsdottir G, Sigurdsson S, Oddsson S, Gudnason V. User Engagement, Acceptability, and Clinical Markers in a Digital Health Program for Nonalcoholic Fatty Liver Disease: Prospective, Single-Arm Feasibility Study. JMIR Cardio 2024;8:e52576 View
25. Freer C, George E, Tan S, Abbott G, Daly R. Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial. British Journal of Nutrition 2024:1 View
26. Chew H, Chew N, Loong S, Lim S, Tam W, Chin Y, Chao A, Dimitriadis G, Gao Y, So J, Shabbir A, Ngiam K. Effectiveness of an Artificial Intelligence-Assisted App for Improving Eating Behaviors: Mixed Methods Evaluation. Journal of Medical Internet Research 2024;26:e46036 View
27. Akbar F, Choirida S, Muttaqin A, Ekayanti F, Nisa H, Hendarto H. Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 2024;14(3):281 View
28. İzgi Tezcan C, Suna G, Karabulak A. Yetişkin Bireylerde E-Sağlık Mobil Uygulama Destekli Beslenme ve Egzersiz Programlarının Vücut Kompozisyonu ve Bazı Kan Parametreleri Üzerine Etkisinin İncelenmesi. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi 2024;15(1):17 View
29. Ozturk N, Tapper E. The rise of mobile apps for the management of chronic liver disease. Hepatology Communications 2024;8(4) View
30. Ang S, Lim S, Dan Y, Chan Y, Yap Q, Chen J. Clinical Service Incorporating Mobile Technology on Weight Loss in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Translation From Research Trial. Endocrinology, Diabetes & Metabolism 2024;7(3) View
31. Simonsson C, Nyman E, Gennemark P, Gustafsson P, Hotz I, Ekstedt M, Lundberg P, Cedersund G. A unified framework for prediction of liver steatosis dynamics in response to different diet and drug interventions. Clinical Nutrition 2024;43(6):1532 View
32. Tegegne T, Shifti D, Rawstorn J, Jansons P, Zhang Y, Daryabeygikhotbehsara R, Islam S, Maddison R. Digital lifestyle interventions for cardiovascular risk reduction: A systematic review and network meta-analysis. Health Policy and Technology 2024;13(3):100879 View
33. Kaewdech A, Assawasuwannakit S, Churuangsuk C, Chamroonkul N, Sripongpun P. Effect of smartphone-assisted lifestyle intervention in MASLD patients: a randomized controlled trial. Scientific Reports 2024;14(1) View
34. Spann A, Feld L, Belledent T, Shingina A. How to improve preventive health care in patients with cirrhosis. Clinical Liver Disease 2024;23(1) View